Trials / Completed
CompletedNCT00762346
Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 156 (actual)
- Sponsor
- Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A multicenter prospective study to assess the efficacy and safety of ZOMETA® in treatment of high-level NTX non small cell lung cancer with bone metastasis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | zometa | zometa 4mg i.v. every 4 weeks for up to 2 years |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2013-03-01
- Completion
- 2013-03-01
- First posted
- 2008-09-30
- Last updated
- 2013-12-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00762346. Inclusion in this directory is not an endorsement.